Patients with late-stage non-small cell lung cancer (NSCLC) receiving supplementary mistletoe treatment in addition to chemotherapy were able to survive significantly longer than patients receiving chemotherapy alone, a new observational study has found.

 

For more information visit us at: iiio.co.in/mistletoe-therapy/#